Contraception
RSSArticles
-
Weight Gain with Contraception
In this prospective cohort study, perceived weight gain was found to be an adequate predictor of actual weight gain. Depot medroxyprogesterone acetate and the contraceptive implant were associated with more weight gain than the copper IUD. -
Quality Family Planning (QFP) — Put it into practice
“Providing Quality Family Planning Services — Recommendations of CDC and the U.S. Office of Population Affairs” is the newest member in the “suite” of family planning recommendations from the Centers for Disease Control and Prevention. -
Use of Cervical Length and Fetal Fibronectin in Preterm Labor
SYNOPSIS: A large 10-center study has validated the concept of screening all patients who are presenting with preterm contractions in the third trimester with cervical length examinations by transvaginal sonography and using fetal fibronectin selectively only in those with cervical lengths between 1.5 and 3.0 cm.
-
Preventing Pertussis: Are Your Patients and Their Families Cocooning
SYNOPSIS: Prior vaccination of both parents with Tdap (¡°cocooning¡±) protects newborn infants from contracting pertussis. -
Swedish Case-control Study Sees Increase in DVT Risk with DMPA: Is This Real?
Synopsis: A large case-control study done in Sweden that evaluated thromboembolic complications in users of hormonal contraception found an increased risk in users of depomedroxyprogesterone acetate and the combined pill. Desogestrel-containing oral contraceptives showed an increase in risk relative to levonorgestrel pills.
-
Does Single or Double Insemination During Ovulation Induction Cycle Increase Pregnancy Rates?
Synopsis: Performing intrauterine insemination with the use of donor sperm twice during a natural or stimulated ovulation induction cycle did not increase pregnancy rates over a single insemination.
-
Hot topic: Medicine that is evidence-based
This year will see development of new evidence-based documents for the family planning resource library: the U.S. Selected Practice Recommendations for Contraceptive Use from the Centers for Disease Control & Prevention (CDC) and the newly-updated Title X Program Guidelines, issued by the Office of Family Planning within the Department of Health & Human Services' Office of Population Affairs. -
Finally! HPV male shot routinely recommended
The Advisory Committee on Immunization Practices (ACIP) has voted to recommend that males be routinely vaccinated against human papillomavirus (HPV), a move many public health officials seeing as a boost for use of the shot. -
New year, new implant: Time to add Nexplanon to contraceptive options
Get ready to offer women Nexplanon, the latest iteration of the contraceptive implant. The subdermal implant is similar to the Implanon device; however, the applicator has been redesigned to facilitate insertion of the implant in the appropriate subdermal position using one hand. -
Rapid syphilis test released in U.S.
A new point-of-care test for syphilis will provide clinicians another tool in battling increases in the sexually transmitted infection (STI). The new test, Syphilis Health Check (Diagnostics Direct, Stone Harbor, NJ), will no longer require lengthy wait times for results, refrigeration, or the drawing of blood to test for the STI.